Renviva Dialysis Center Of Clearwater, Llc in Clearwater, Florida - Dialysis Center

Renviva Dialysis Center Of Clearwater, Llc is a medicare approved dialysis facility center in Clearwater, Florida and it has 2 dialysis stations. It is located in Pinellas county at 401 Corbett, Clearwater, FL, 33756. You can reach out to the office of Renviva Dialysis Center Of Clearwater, Llc at (727) 281-4490. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Renviva Dialysis Center Of Clearwater, Llc has the following ownership type - Profit. It was first certified by medicare in April, 2017. The medicare id for this facility is 682619 and it accepts patients under medicare ESRD program.

Name	Renviva Dialysis Center Of Clearwater, Llc
Location	401 Corbett, Clearwater, Florida
No. of Dialysis Stations	2
Medicare ID	682619
Managed By	Independent
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Renviva Dialysis Center Of Clearwater, Llc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

Dialysis patients with Hemoglobin data

3

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Peritoneal Dialysis

  Adult patients getting regular peritoneal dialysis at the center	13
  Adult patient months included in Kt/V greater than or equal to 1.7	46
  Percentage of adult patients getting regular peritoneal dialysis at the center	43
  Percentage of pediatric patients getting regular peritoneal dialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Renviva Dialysis Center Of Clearwater, Llc with elevated calcium levels.

Patients with hypercalcemia	14
Hypercalcemia patient months	52
Patients with Serumphosphor	15
Patients with Serumphosphor less than 3.5 mg/dL	3
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	26
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	46
Patients with Serumphosphor from 5.6 to 7 mg/dL	23
Patients with Serumphosphor greater than 7 mg/dL	3

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	1
Patient months included in arterial venous fistula and catheter summaries	6
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer